(Natural News) The American College of Physicians (ACP) has released an updated guidance statement about how to treat type-2 diabetes that significantly scales back the group’s official recommendations concerning drug-based interventions for the blood sugar condition.
Because pharmacologic therapies for type-2 diabetes come with some serious health risks, the ACP is now recommending that physicians take a more conservative approach in administering them. Rather than try to achieve what are now being regarded as impossibly low blood sugar level targets, the ACP says that doctors should instead focus on more minor reductions.
The problem is that too many type-2 diabetics are suffering heart attacks and early death as a result of taking the pharmaceuticals prescribed by their doctors. Based on the latest available data about some of the newer type-2 diabetes drugs on the market today, the ACP is advising that physicians instead pay more attention to potential adverse effects, and focus less on simply trying to bring down blood sugar levels.
“Some anticipate that treatment decisions will eventually be based more on cardiovascular risk than achievement of specific HbA1c (hemoglobin A1c) targets, analogous to recent changes in lipid management,” the guidance explains.